You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1451 to 1475 of about 5880
Next 25
05/20/2017
Market Research Opportunity for GBM Patients - ONLINE SURVEY
Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients.
05/19/2017
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
05/14/2017
Tumor treating fields in pediatric high-grade glioma.
Long-Term Follow-Up Data from 126 Patients with Recurrent High Grade Glioma from Three Phase 1 Trials of Toca 511 and Toca FC: Update and Justification for a Phase 2/3 Trial
Long-term benefit of intra-arterial bevacizumab for recurrent glioblastoma.
05/11/2017
First spherical nucleic acid drug injected into humans targets brain cancer
Inovio, Regeneron Plan Clinical Trial of Triple-Combo Immunotherapy for Brain Tumors
05/08/2017
DelMar Presents New Mechanism of Action Data for its Lead Agent VAL-083 in Temozolomide-Resistant Glioblastoma Multiforme (GBM) at the World Federation of Neuro-Oncology Societies (WFNOS)
05/05/2017
Duke researchers develop treatment that triples survival time of brain cancer patients
05/04/2017
Novocure (NVCR) to Open Two Pilot Trials to Evaluate the Use of TTFields for Pediatric
Research Reveals Non-coding RNA SPRIGHTLY Plays Important Role in Tumour Growth, Spread
Brain cancer: Study sheds light on unexpected link between glioma and blood sugar
05/02/2017
Using CRISPR to Find Treatments For Aggressive Pediatric Brain Cancers
05/01/2017
Breakthrough brain tumour visualisation drug Gliolan to be listed on NZ hospital medicines list from 1 June
Musella Foundation Copay Assistance Program reopens!
Brain Tumor BioTech Conference June 2, 2017 in NY
04/26/2017
TARGETED THERAPY BEING TESTED IN SOCAL GIVES BRAIN CANCER PATIENTS HOPE
Surgical success in previously “inoperable” brain cancers
New Tupperware Fundraiser!
04/22/2017
Brains Matter Awareness Fundraiser and Celebration Luncheon / Now Accepting Nomination for our 2017 National Hope Award
04/21/2017
Pediatric Brain Tumor Mutations are Detectable in Cerebrospinal Fluid
04/20/2017
VBL Therapeutics Announces Positive DSMC Review in Phase 3 GLOBE Trial Investigating VB-111 in rGBM
04/19/2017
Effect of gross total resection (GTR) in WHO grade II astrocytomas: A SEER based survival analysis.
Cloud Over Pediatric Oncologist and Brain Cancer Vaccine